An independent review undertaken by the New South Wales government found that puberty blockers for transgender youth are generally safe, with reversible effects. The review's findings highlight the overall benefits of these medications, despite rising scrutiny. It asserts that scientific evidence does not indicate that their usage is harmful, paving the way for their continued application in gender-affirming care.
The report by the Sax Institute highlighted the need for more robust research, stating that many existing studies on puberty blockers are 'limited to poor' standards. This means clinicians may struggle to make well-informed decisions about treatments for transgender youth due to a lack of quality studies that adequately compare different approaches or control groups.
Additionally, the review emphasizes the complexities in assessing gender-affirming care models, citing how multi-faceted treatment strategies can complicate research comparisons. The report points out that studies often lack control or reference groups, hindering precise evaluations for clinicians aiming to provide the best individualized care.
Ultimately, the Sax Institute concluded that much of the existing evidence regarding puberty blockers remains limited and calls for more rigorous research to support clinicians while ensuring the safety and effectiveness of treatments for young transgender individuals.
[
Collection
]
[
|
...
]